The next evolution of
biomanufacturing
We deliver the next generation of bioprocess technologies by leveraging the strengths of process intensification and chaining


Life Science evolves.
Donaldson solves.
Univercells Technologies is part of Donaldson and its focus on Life Sciences and Bioprocessing.
Products
We design innovative cost-
effective manufacturing solutions
scale-X™ bioreactor
Intensified fixed-bed technology for
cost-effective & scalable viral production
NevoLine™ Upstream platform
Integrated & automated solution
for intensified virus manufacturing
Publications
Leveraging small-scale parallel bioreactor systems for reliable and scalable processing design
Our Product Manager Clément Dumont explains how an innovative fixed-bed small-scale parallel system will revolutionize process design & optimization steps resulting in an increased production capacity & quality.
DownloadSuspension-based viral vector production in scale-X fixed-bed bioreactor
Shake flask process transferred in a scale-X hydro fixed-bed bioreactor for Adenovirus production with HEK293 cells adapted to suspension.
Learn moreIntegrated continuous biomass estimation in fixed-bed bioreactors
Novel approach allows for real-time measurement of cell density in fixed-bed bioreactors
Learn moreCustomer experiences that are built to last
We support your manufacturing success
From 37 answers over 16 months
Newsroom
The scale-X nexo accelerated and facilitated the CER’s process development journey, with reduced COGs due to its small surface and volume.
Read article “CER Groupe uses scale-X™ nexo bioreactor for efficient early-stage development”Univercells Technologies by Donaldson introduces the scale-X nexo bioreactor – offering a 0.5 m² growth surface, designed for efficient cell culture process development across multiple modalities.
Read article “Univercells Technologies by Donaldson launches the scale-X™ nexo mini bioreactor for cost-efficient, scalable cell culture process development across modalities”